140 related articles for article (PubMed ID: 19929606)
21. Six decades searching for meaning in the proteome.
Anderson L
J Proteomics; 2014 Jul; 107():24-30. PubMed ID: 24642211
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics in mass spectrometry data analysis for proteomics studies.
Cristoni S; Bernardi LR
Expert Rev Proteomics; 2004 Dec; 1(4):469-83. PubMed ID: 15966842
[TBL] [Abstract][Full Text] [Related]
23. Proteomics technology in systems biology.
Smith JC; Figeys D
Mol Biosyst; 2006 Aug; 2(8):364-70. PubMed ID: 16880956
[TBL] [Abstract][Full Text] [Related]
24. Proteomics of breast cancer: the quest for markers and therapeutic targets.
Hondermarck H; Tastet C; El Yazidi-Belkoura I; Toillon RA; Le Bourhis X
J Proteome Res; 2008 Apr; 7(4):1403-11. PubMed ID: 18311906
[TBL] [Abstract][Full Text] [Related]
25. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
26. Shotgun proteomics of cyanobacteria--applications of experimental and data-mining techniques.
Barrios-Llerena ME; Chong PK; Gan CS; Snijders AP; Reardon KF; Wright PC
Brief Funct Genomic Proteomic; 2006 Jun; 5(2):121-32. PubMed ID: 16772275
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics and data mining in proteomics.
Haoudi A; Bensmail H
Expert Rev Proteomics; 2006 Jun; 3(3):333-43. PubMed ID: 16771705
[TBL] [Abstract][Full Text] [Related]
28. Ions of the interactome: the role of MS in the study of protein interactions in proteomics and structural biology.
Downard KM
Proteomics; 2006 Oct; 6(20):5374-84. PubMed ID: 16991196
[TBL] [Abstract][Full Text] [Related]
29. Brazil: the country of proteomics.
Martins-de-Souza D
Proteomics; 2012 Aug; 12(17):2599-600. PubMed ID: 22927311
[No Abstract] [Full Text] [Related]
30. PPI spider: a tool for the interpretation of proteomics data in the context of protein-protein interaction networks.
Antonov AV; Dietmann S; Rodchenkov I; Mewes HW
Proteomics; 2009 May; 9(10):2740-9. PubMed ID: 19405022
[TBL] [Abstract][Full Text] [Related]
31. Reverse-phase protein microarrays for tissue-based analysis.
Speer R; Wulfkuhle JD; Liotta LA; Petricoin EF
Curr Opin Mol Ther; 2005 Jun; 7(3):240-5. PubMed ID: 15977421
[TBL] [Abstract][Full Text] [Related]
32. Rice proteomics: ending phase I and the beginning of phase II.
Agrawal GK; Jwa NS; Rakwal R
Proteomics; 2009 Feb; 9(4):935-63. PubMed ID: 19212951
[TBL] [Abstract][Full Text] [Related]
33. Hares and tortoises: the high- versus low-throughput proteomic race.
Wilkins MR
Electrophoresis; 2009 Jun; 30 Suppl 1():S150-5. PubMed ID: 19441020
[TBL] [Abstract][Full Text] [Related]
34. A personal account of the early stages of proteomics at Aarhus University.
Celis JE
J Proteomics; 2014 Jul; 107():31-8. PubMed ID: 24473278
[TBL] [Abstract][Full Text] [Related]
35. Proteomics: the first decade and beyond.
Patterson SD; Aebersold RH
Nat Genet; 2003 Mar; 33 Suppl():311-23. PubMed ID: 12610541
[TBL] [Abstract][Full Text] [Related]
36. PROTEOMICS: The first 15 years.
Proteomics; 2016 Jan; 16(1):1-3. PubMed ID: 26728305
[No Abstract] [Full Text] [Related]
37. Redox pioneer: professor Roland Stocker.
Hunt NH
Antioxid Redox Signal; 2011 Dec; 15(12):3101-5. PubMed ID: 21609251
[TBL] [Abstract][Full Text] [Related]
38. Individualized proteomics.
Forler S; Klein O; Klose J
J Proteomics; 2014 Jul; 107():56-61. PubMed ID: 24732725
[TBL] [Abstract][Full Text] [Related]
39. From the laboratory to the patient and back--an interview with Marc Mareel. Interview by Marc E. Bracke.
Mareel M
Int J Dev Biol; 2011; 55(7-9):697-702. PubMed ID: 22161826
[TBL] [Abstract][Full Text] [Related]
40. Interview: interview with Gisbert Schneider.
Schneider G
Future Med Chem; 2012 Oct; 4(15):1881-3. PubMed ID: 23088268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
